Thermo Fisher Scientific (TMO) offers growth potential with diverse revenue streams, fair valuation, and strong CAGR ...

Respondents agreed that the level of risk in pharmaceutical supply chains has increased across the board since 2023, although perceptions about the degree of escalation vary. Fifty-six (56%) percent ...

The Global Equity composite fell 0.86% gross of fees in the fourth quarter, in line with the 0.89% decline of the MSCI ACWI ...

Faced with mounting hyperscaler bills, proliferating data and compute-hungry generative AI, enterprises are weighing ...

the global pandemic has strengthened Ireland’s position as a hub for biopharma in Europe. This is due to the need to ensure ‘geographic resilience’ across supply chains, and companies re ...

London’s WOO architects and structures specialist ES Global have revealed fresh designs for a UK pavilion to feature at the ...

Around 80% of biopharma companies have set net zero or ... A solid investment must be made to discover risk and build asset resilience over the coming years,” said the paper.

This test is for anyone who struggles with resilience or wants to learn more about their approach to life. This test is designed for adults and is not intended to be diagnostic.

McKesson's strategic growth in oncology, biopharma and tech drives momentum in 2025. Will MCK overcome its sustaining challenges with robust finances and innovation?

Following the strange year for the biopharma industry that was 2024, insiders and analysts alike are waiting expectantly to see how trends in layoffs, drug shortages, clinical trials and more play ...